QL
AVDL

Quarry LP’s Avadel Pharmaceuticals AVDL Stock Holding History

Quarry LP’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38,300
Closed -$339K – 2177
2025
Q2 		$339K Buy
38,300
+26,300
+219% +$231K 0.07% 250
2025
Q1 		$94K Buy
+12,000
New +$100K 0.02% 543
2024
Q4 		– Sell
-14,000
Closed -$184K – 1626
2024
Q3 		$184K Buy
14,000
+9,500
+211% +$145K 0.05% 252
2024
Q2 		$63.3K Buy
+4,500
New +$73.3K 0.02% 531
2024
Q1 		– Sell
-8,500
Closed -$120K – 1643
2023
Q4 		$120K Buy
+8,500
New +$99.8K 0.02% 185

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Quarry LP's AVDL Position: Q3 2025 in Review

Quarry LP sold out of Avadel Pharmaceuticals (AVDL) in Q3 2025, closing a stake of 38,300 shares — an estimated $339K sold.

Quarry LP first reported a position in AVDL in Q4 2023 and held it in 5 quarters. The position peaked at $339K in Q2 2025. 188 funds tracked by Wall St. Rank hold AVDL as of Q3 2025.

  • Quarry LP reported no remaining Avadel Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Quarry LP sold 38,300 Avadel Pharmaceuticals shares in Q3 2025, an estimated $339K.
  • Quarry LP first reported a position in Avadel Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Quarry LP's Avadel Pharmaceuticals position peaked at $339K in Q2 2025.
  • 188 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2025.

Based on Quarry LP's 13F filing for Q3 2025, filed 14 Nov 2025.